Ropes & Gray Counsels Pfizer in $17 Billion Acquisition of Hospira

In The News
February 5, 2015

Ropes & Gray advised Pfizer Inc. on its definitive agreement to acquire Hospira, the Lake Forest, Ill.-based leading provider of injectable drugs and infusion technologies and a worldwide leader in biosimilars, for a total value of approximately $17 billion. The deal was announced Feb. 5 and is expected to close in the second half of 2015.

Securities & public companies partners Marko Zatylny and Paul Kinsella led the Ropes & Gray team advising Pfizer on the transaction.